The hairy-print for levamisole-induced vasculitis

BMJ Case Reports

Volumn , Issue , 2012, Pages

  Lazareth, Hélène ^a   Peytavin, Gilles ^a   Polivka, Laura ^a   Dupin, Nicolas ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; ENZYME ANTIBODY; LEVAMISOLE; METHOTREXATE; MYELOPEROXIDASE ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; UNCLASSIFIED DRUG;

ADULT; ANCA ASSOCIATED VASCULITIS; ANTIBODY DETECTION; ANTIBODY TITER; ARTHRALGIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; COCAINE DEPENDENCE; DRUG ABUSE; ENT EXAMINATION; ENZYME SPECIFICITY; ERYTHEMA; FEMALE; FEVER; HAIR ANALYSIS; HAIR LEVEL; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; MEDICAL HISTORY; NOSE SEPTUM PERFORATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RHINITIS; SKIN BIOPSY; SKIN DEFECT; TREATMENT OUTCOME;

EID: 84865588142     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2012-006602     Document Type: Article

References (6)

1. Lynch KL, Dominy SS, Graf J, et al. Detection of levamisole exposure in cocaine users by liquid chromatography-tandem mass spectrometry. J Anal Toxicol 2011;35:176-8.
2. Kintz P, Ludes B, Mangin P. Detection of drugs in human hair using Abbott ADx, with confirmation by gas chromatography/mass spectrometry (GC/MS). J Forensic Sci 1992;37:328-31.
3. Scheinberg MA, Bezerra JB, Almeida FA, et al. Cutaneous necrotising vasculitis induced by levamisole. Br Med J 1978;1:408. (Pubitemid 8318799)
4. Gross RL, Brucker J, Bahce-Altuntas A, et al. A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaïne. Clin Rheumatol 2011; 30:1385-92.
5. Woestenborghs R, Michielsen L, Heykants J. Determination of levamisole in plasma and animal tissues by gas chromatography with thermionic specific detection. J Chromatogr 1981;224:25-32. (Pubitemid 11006742)
6. Schneider S, Meys F. Analysis of illicit cocaine and heroin samples seized in Luxembourg from 2005-2010. Forensic Sci Int 2011;212:242-6.